Login Register Cart 0
Generic placeholder image

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5230
ISSN (Online): 1875-614X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

The Correlation Between the Autotaxin Enzyme and Pruritus in Egyptian Patients Suffering from Chronic Liver Disease

Author(s): Fathia Asal, Dina Ziada, Ayman Wageh, Mohammed El-Kohy, Nehad Hawash, Sherief Abd-Elsalam* and Rehab Badawi

Volume 20, Issue 3, 2021

Published on: 14 January, 2021

Page: [302 - 307] Pages: 6

DOI: 10.2174/1871523020666210114092924

Price: $65

Abstract

Background &Aims: Pruritus associated with liver diseases confines daily activities and causes sleep deprivation in patients with chronic liver diseases. Autotoxin enzyme (ATX) was found to be higher in sera of patients with intrahepatic cholestasis and it was found to be associated with the intensity of itching. The aim of this study was to assess the correlation between the autotaxin enzyme and pruritus in Egyptian patients suffering from chronic liver disease (CLD).

Methods: This cross-sectional study was carried on a total number of 80 patients with chronic liver disease divided into four groups: Group A and B included cirrhotic patients suffering from pruritis with and without cholestasis, while group C and D included patients without pruritis with or without cholestasis and group E included 17 healthy controls. They were subjected to measurement of serum autotoxin concentration by ELISA in addition to routine investigations including liver function tests: Total and direct bilirubin, ALT, AST, Alkaline phosphatase, Gama- glutamyl transferase, and serum albumin.

Results: There was a significant increase in autotaxin in the four groups included chronic liver disease patients (P-value <0.001*) compared to control group (group E). Autotoxin level was the only marker that had a significant increase in pruritus groups (groups A & B) compared to non-pruritus groups (groups C & D) with cut off value ≥ 32.

Conclusion: Serum autotaxin level was elevated in patients with chronic liver diseases with pruritus. Autotaxin enzyme may play a key role in the induction of hepatogenic pruritus. So, autotaxin enzyme inhibitors and lysophosphatidic acid (LPA) receptor blockers could be a future line of treatment of hepatogenic pruritus.

Keywords: Chronic liver disease, cirrhosis, decompensated, cholestasis, pruritus, egypt.

« Previous Next »
Graphical Abstract

[1]
Koulentaki, M.; Ioannidou, D.; Stefanidou, M.; Maraki, S.; Drigiannakis, I.; Dimoulios, P.; Melono, J.M.; Tosca, A.; Kouroumalis, E.A. Dermatological manifestations in primary biliary cirrhosis patients: a case control study. Am. J. Gastroenterol., 2006, 101(3), 541-546.
[http://dx.doi.org/10.1111/j.1572-0241.2006.00423.x] [PMID: 16464228]
[2]
Cacoub, P.; Poynard, T.; Ghillani, P.; Charlotte, F.; Olivi, M.; Piette, J.C.; Opolon, P. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum., 1999, 42(10), 2204-2212.
[http://dx.doi.org/10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D] [PMID: 10524695]
[3]
Kremer, A.E.; Martens, J.J.; Kulik, W.; Ruëff, F.; Kuiper, E.M.; van Buuren, H.R.; van Erpecum, K.J.; Kondrackiene, J.; Prieto, J.; Rust, C.; Geenes, V.L.; Williamson, C.; Moolenaar, W.H.; Beuers, U.; Oude Elferink, R.P. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology, 2010, 139(3), 1008-1018.
[http://dx.doi.org/10.1053/j.gastro.2010.05.009] [PMID: 20546739]
[4]
Kremer, A.E.; Martens, J.J.; Kulik, W.; Williamson, C.; Moolenaar, W.H.; Kondrackiene, J. Autotaxin but not bile salts correlate with itch intensity in cholestasis. J. Hepatol., 2010, 52, S1.
[http://dx.doi.org/10.1016/S0168-8278(10)00232-1]
[5]
Ferry, G.; Tellier, E.; Try, A.; Grés, S.; Naime, I.; Simon, M.F.; Rodriguez, M.; Boucher, J.; Tack, I.; Gesta, S.; Chomarat, P.; Dieu, M.; Raes, M.; Galizzi, J.P.; Valet, P.; Boutin, J.A.; Saulnier-Blache, J.S. Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity. J. Biol. Chem., 2003, 278(20), 18162-18169.
[http://dx.doi.org/10.1074/jbc.M301158200] [PMID: 12642576]
[6]
Jansen, S.; Stefan, C.; Creemers, J.W.; Waelkens, E.; Van Eynde, A.; Stalmans, W.; Bollen, M. Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D. J. Cell Sci., 2005, 118(Pt 14), 3081-3089.
[http://dx.doi.org/10.1242/jcs.02438] [PMID: 15985467]
[7]
Iwasawa, Y.; Fujii, T.; Nagamatsu, T.; Kawana, K.; Okudaira, S.; Miura, S.; Matsumoto, J.; Tomio, A.; Hyodo, H.; Yamashita, T.; Oda, K.; Kozuma, S.; Aoki, J.; Yatomi, Y.; Taketani, Y. Expression of autotaxin, an ectoenzyme that produces lysophosphatidic acid, in human placenta. Am. J. Reprod. Immunol., 2009, 62(2), 90-95.
[http://dx.doi.org/10.1111/j.1600-0897.2009.00715.x] [PMID: 19614625]
[8]
Fotopoulou, S.; Oikonomou, N.; Grigorieva, E.; Nikitopoulou, I.; Paparountas, T.; Thanassopoulou, A.; Zhao, Z.; Xu, Y.; Kontoyiannis, D.L.; Remboutsika, E.; Aidinis, V. ATX expression and LPA signalling are vital for the development of the nervous system. Dev. Biol., 2010, 339(2), 451-464.
[http://dx.doi.org/10.1016/j.ydbio.2010.01.007] [PMID: 20079728]
[9]
Nakasaki, T.; Tanaka, T.; Okudaira, S.; Hirosawa, M.; Umemoto, E.; Otani, K.; Jin, S.; Bai, Z.; Hayasaka, H.; Fukui, Y.; Aozasa, K.; Fujita, N.; Tsuruo, T.; Ozono, K.; Aoki, J.; Miyasaka, M. Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions. Am. J. Pathol., 2008, 173(5), 1566-1576.
[http://dx.doi.org/10.2353/ajpath.2008.071153] [PMID: 18818380]
[10]
Bergasa, N.V. lysophosphatidic acid and autotaxin in patients with cholestasis and pruritis. Ann. Hepatol., 2010, 9(4), 475-479.
[http://dx.doi.org/10.1016/S1665-2681(19)31629-1] [PMID: 21057172]
[11]
Tokumura, A.; Majima, E.; Kariya, Y.; Tominaga, K.; Kogure, K.; Yasuda, K.; Fukuzawa, K. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem., 2002, 277(42), 39436-39442.
[http://dx.doi.org/10.1074/jbc.M205623200] [PMID: 12176993]
[12]
Umezu-Goto, M.; Kishi, Y.; Taira, A.; Hama, K.; Dohmae, N.; Takio, K.; Yamori, T.; Mills, G.B.; Inoue, K.; Aoki, J.; Arai, H. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol., 2002, 158(2), 227-233.
[http://dx.doi.org/10.1083/jcb.200204026] [PMID: 12119361]
[13]
Nakanaga, K.; Hama, K.; Aoki, J. Autotaxin-An LPA producing enzyme with diverse functions. J. Biochem., 2010, 148(1), 13-24.
[http://dx.doi.org/10.1093/jb/mvq052] [PMID: 20495010]
[14]
Patrick, S K Clinical approach to the patient with abnormal liver test results. Mayo Clin. Proc., 1996, 71(11), 1089-1095.
[15]
Whitfield, JB Gamma glutamyltransferase. Crit. Rev. Clin. Lab. Sci., 2001, 38(4), 263-355.
[16]
Zajic, S.; Damnjanovic, Z.; Stojanovic, M. Biochemical markers in patients with extrahepatic cholestasis. Actamedicamedianae, 2008, 47(1), 5-12.
[17]
Abd-Elsalam, S.; Ebrahim, S.; Soliman, S.; Alkhalawany, W.; Elfert, A.; Hawash, N. Orphenadrine in treatment of muscle cramps in cirrhotic patients: A randomized study. Eur. J. Gastroenterol. Hepatol., 2020, 32(8), 1042-1045.
[http://dx.doi.org/10.1097/MEG.0000000000001310] [PMID: 31834056]
[18]
Soliman, H.; Ziada, D.; Salama, M.; Hamisa, M.; Badawi, R.; Hawash, N.; Selim, A.; Abd-Elsalam, S. Predictors for fibrosis regression in chronic HCV patients after the treatment with DAAS: Results of a real-world cohort study. Endocr. Metab. Immune Disord. Drug Targets, 2020, 20(1), 104-111.
[http://dx.doi.org/10.2174/1871530319666190826150344] [PMID: 31448717]
[19]
Kamath, P.S.; Wiesner, R.H.; Malinchoc, M.; Kremers, W.; Therneau, T.M.; Kosberg, C.L.; D’Amico, G.; Dickson, E.R.; Kim, W.R. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001, 33(2), 464-470.
[http://dx.doi.org/10.1053/jhep.2001.22172] [PMID: 11172350]
[20]
Rizk, F.H.; Sarhan, N.I.; Soliman, N.A.; Ibrahim, M.A.A.; Abd-Elsalam, M.; Abd-Elsalam, S. Heat shock protein 47 as indispensible participant in liver fibrosis: Possible protective effect of lactoferrin. IUBMB Life, 2018, 70(8), 795-805.
[http://dx.doi.org/10.1002/iub.1884] [PMID: 30092114]
[21]
Tawfik, A.K.; Amin, A.M.; Yousef, M.; El-Sayd, N.M.; Elashry, H.; Elkadeem, M.; Abd-Elsalam, S. IL-1α correlates with severity of hepatitis C virus-related liver diseases. J. Inflamm. Res., 2018, 11, 289-295.
[http://dx.doi.org/10.2147/JIR.S166564] [PMID: 30022847]
[22]
Sharaf-Eldin, M.; Bediwy, A.S.; Kobtan, A.; Abd-Elsalam, S.; El-Kalla, F.; Mansour, L.; Elkhalawany, W.; Elhendawy, M.; Soliman, S. Pigtail catheter: A less invasive option for pleural drainage in egyptian patients with recurrent hepatic hydrothorax. Gastroenterol. Res. Pract., 2016, 2016, 4013052.
[http://dx.doi.org/10.1155/2016/4013052] [PMID: 27340399]
[23]
Pugh, R.N.; Murray-Lyon, I.M.; Dawson, J.L.; Pietroni, M.C.; Williams, R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg., 1973, 60(8), 646-649.
[http://dx.doi.org/10.1002/bjs.1800600817] [PMID: 4541913]
[24]
Nakamura, K.; Nangaku, M.; Ohkawa, R.; Okubo, S.; Yokota, H.; Ikeda, H.; Aoki, J.; Yatomi, Y. Analysis of serum and urinary lysophospholipase D/autotaxin in nephrotic syndrome. Clin. Chem. Lab. Med., 2008, 46(1), 150-151.
[http://dx.doi.org/10.1515/CCLM.2008.025] [PMID: 18034642]
[25]
Pleli, T.; Martin, D.; Kronenberger, B.; Brunner, F.; Köberle, V.; Grammatikos, G.; Farnik, H.; Martinez, Y.; Finkelmeier, F.; Labocha, S.; Ferreirós, N.; Zeuzem, S.; Piiper, A.; Waidmann, O. Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis-A prospective cohort study. PLoS One, 2014, 9(7), e103532.
[http://dx.doi.org/10.1371/journal.pone.0103532] [PMID: 25062038]
[26]
Sharma, P.; Schaubel, D.E.; Sima, C.S.; Merion, R.M.; Lok, A.S. Re-weighting the model for end-stage liver disease score components. Gastroenterology, 2008, 135(5), 1575-1581.
[http://dx.doi.org/10.1053/j.gastro.2008.08.004] [PMID: 18835388]
[27]
Tokumura, A; Majima, E; Kariya, Y Identification of human plasmalysophospholipase D, a lysophosphatidic acid-producing enzyme, asautotaxin, a multifunctional phosphodiesterase. J Biol Chem., 2002, 277, 39436-39442.
[28]
Kremer, A.E.; van Dijk, R.; Leckie, P.; Schaap, F.G.; Kuiper, E.M.; Mettang, T.; Reiners, K.S.; Raap, U.; van Buuren, H.R.; van Erpecum, K.J.; Davies, N.A.; Rust, C.; Engert, A.; Jalan, R.; Oude Elferink, R.P.; Beuers, U. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions. Hepatology, 2012, 56(4), 1391-1400.
[http://dx.doi.org/10.1002/hep.25748] [PMID: 22473838]

Rights & Permissions Print Cite
Article Metrics
16
2
© 2024 Bentham Science Publishers | Privacy Policy